Poland· PL-100311369
Leflunomide Zentiva
A leflunomid product containing leflunomidum, registered in Poland by Zentiva, k.s.. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Leflunomid is registered in 4 of 19 countries.
Countries holding a registration under ATC L04AA13 (leflunomid), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Leflunomid · ATC L04AA13
4 / 19 countries
- Belgiumprice
- Ireland
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Leflunomidum
- Manufacturer
- Zentiva, k.s.
- Country
- Poland (PL)
- ATC code
- L04AA13
- ATC class
- Leflunomid
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909991416676
- gtin05909991416690
- gtin05909991416683
- gtin05909991416706
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
805 interactions on record for leflunomid.
Graded by severity as the source publishes them — 537 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Leflunomid · interactions on record
805 records
- 537 severe
- 47 moderate
- 7 minor
- 214 info
Most severe, free to view
- ClotrimazoleA01AB18severe
- Chenodeoxycholic acidA05AA01severe
- PrednisoloneA07EA01severe
- HydrocortisoneA07EA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Leflunomid in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaARAVASanofi-Aventis Deutschland GmbH, Frankfurt am Main
- SpainARAVA 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULASanofi-Aventis Deutschland Gmbh
- BelgiumArava 10 mgPI Pharma
- SwitzerlandArava
- United StatesAravasanofi-aventis U.S. LLC
- FinlandAravaSanofi-Aventis Deutschland GmbH
- NetherlandsArava 10 mg, filmomhulde tablettenSanofi-Aventis Deutschland GmbH
- FranceARAVA 10 mg, comprimé pelliculéSANOFI AVENTIS (ALLEMAGNE)
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Leflunomid Stada
- Belgium · Leflunomid Sandoz, Leflunomide Ab
- Bulgaria · Багеда
- Cyprus · Arotan
- Czechia · Leflon, Leflugen
- Germany · Leflon, Leflunomid 1 A Pharma
- Denmark · Leflunomid, Leflunomid "egis"
- Estonia · Leflunomide Elvim
- Spain · Lefluartil, Leflunomida Aurovitas
- Finland · Leflunomide Orion, Leflunomide Stada
- France · Leflunomide Arrow, Leflunomide Biogaran
- United Kingdom (Northern Ireland) · Leflunomide Aspire Pharma, Leflunomide Milpharm
- Greece · Lefid, Lefluonia
- Hungary · Leflunomid Sandoz
- Ireland · Leflunomide Aspire Pharma (Malta)
- Iceland · Arava, Leflunomide Medac
- Italy · Leflunomide Aurobindo, Leflunomide Mylan
- Liechtenstein · Arava, Leflunomide Medac
- Lithuania · Leflunomide Elvim, Leflunomide Sandoz
- Latvia · Leflunomide Elvim, Leflunomide Sandoz
- Malta · Leflunomide Normon
- Netherlands · Leflunomide Aurobindo, Leflunomide Cf
- Norway · Arava, Leflunomide Medac
- Portugal · Leflunomida Farmoz, Leflunomida Generis
- Romania · Leflon, Leflunomidă Arena
- Sweden · Leflunomid Bluefish
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e9e803ad-121b-43c5-82c3-5bde6b6e0c90 GET /v1/drugs/e9e803ad-121b-43c5-82c3-5bde6b6e0c90?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "10 mg",
"packaging": "05909991416676 ¦ Rpz ¦ EU/1/09/604/003 ¦ 89575\n30 tabl. w blistrze\n05909991416690 ¦ Rpz ¦ EU/1/09/604/004 ¦ 89576\n100 tabl. w blistrze\n05909991416683 ¦ Rpz ¦ EU/1/09/604/001 ¦ 89577\n1 butelka 30 tabl.\n05909991416706 ¦ Rpz ¦ EU/1/09/604/002 ¦ 89578\n1 butelka 100 tabl.",
"substance": "Leflunomidum 10 mg",
"common_name": "Leflunomidum",
"pl_product_id": "100311369",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about leflunomid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.